Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.

Weight loss drugs can be purchased online with ease, and a boom in sales exposes consumers to risk. #EuropeNews ...

An FDA deadline instructing compounding pharmacies and telehealth companies to stop selling compounded versions of Ozempic and Zepbound has not stopped the copycat market, The Wall Street Journal ...

A government crackdown on cheaper copies of Ozempic and similar diabetes and weight-loss drugs was intended to shut the door on that booming market. It hasn’t exactly worked out that way.

As Ozempic and other GLP-1 drugs explode ... forces of social media-driven demand and regulatory loopholes in the pharmaceutical market? The ongoing battle against counterfeit GLP-1 drugs and ...

While the runaway success of Novo’s GLP-1 drugs Ozempic and Wegovy made ... to flood the market with knock-off copies. While semaglutide is no longer in shortage — closing that loophole — the copycat ...

Shell Canada's decision on whether to pursue Phase 2 of LNG Canada will depend on other opportunities that are available, ...